aTyr Pharma Announces Two Abstracts for ATYR1923 Accepted for Presentation at the European Respiratory Society International Congress

NEXT STORY
TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial
PREV STORY
Agenus Corporate Update and Second Quarter 2021 Financial Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Published Studies Confirm Cisplatin Remains Preferred Chemotherapy Component in Head and Neck Cancer Treatment; Innovation Pharmaceuticals on Target with Clinical Trials of Brilacidin for Preventing Severe Oral Mucositis

Company to Approach European Medicines Agency for International Development GuidanceBEVERLY, Mass., Jan. 08, 2019 ...

author_avatar
NASDAQ Market News

Immunomedics Receives Edison Patent Award From Research & Development Council of New Jersey for the Fourth Time

MORRIS PLAINS, N.J., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced ...

author_avatar
NASDAQ Market News

Celsion Corporation Reports Second Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News